• Department of Ophthalmology, Peking University People’s Hospital, Beijing Key Laboratory of Ocular Disease and Optometry Science, Beijing 100044, China;
Zhao Mingwei, Email: dr_zhaomingwei@163.com
Export PDF Favorites Scan Get Citation

The release of Expert consensus on quality control for intravitreal injections in China (2026) marks a systematic transformation in the quality management of intravitreal injections (IVI) in China, shifting from an empirical model to an evidence-based and standardized approach. This interpretation focuses on the eight core issues outlined in the consensus and elaborates on four key dimensions to be emphasized in clinical practice. First, regarding the substantial update of infection prevention strategies, the consensus no longer recommends routine prophylactic antibiotic use during the perioperative period. Instead, it establishes standardized disinfection procedures using povidone-iodine as the core measure for infection prevention. This update requires a clinical shift from relying on drug prophylaxis to ensuring strict aseptic techniques and standardized disinfection protocols. Second, adjustments to operational techniques are necessary due to new drugs. The unique physicochemical properties of high-dose anti-vascular endothelial growth factor formulations and intraocular glucocorticoid implants require targeted optimization of injection techniques. This includes the selection of needle gauges, determination of injection sites, and adjustment of injection angles. Consequently, previous operational habits suitable for low-dose conventional drugs need to be revised accordingly. Third, quality risk control is now proactively integrated throughout the entire process. The consensus shifts the prevention of adverse events, such as sterile intraocular inflammation, upstream to the drug storage, temperature equilibration, and preparation phases. It emphasizes details such as avoiding agitation, using silicone oil-free syringes, and preferring pre-filled syringes, reflecting a systematic approach to extending quality control across the whole workflow. Fourth, a framework for stratified management and individualized decision-making has been established. For aspects such as intraocular pressure monitoring and dose adjustment, the consensus provides a risk-stratified management framework, offering a practical pathway for individualized clinical decision-making. This interpretation aims to assist ophthalmologists in understanding the evidence-based logic and clinical implications of the consensus, converting recommendations into actionable practices for daily work, and effectively enhancing the standardization of IVI treatment and patient safety in China.

Citation: Miao Heng, Li Xiaoxin, Zhao Mingwei. Interpretation of Expert consensus on quality control for intravitreal injections in China (2026). Chinese Journal of Ocular Fundus Diseases, 2026, 42(10): 838-841. doi: 10.3760/cma.j.cn511434-20260625-00272 Copy

Copyright ? the editorial department of Chinese Journal of Ocular Fundus Diseases of West China Medical Publisher. All rights reserved

  • Previous Article

    Clinical classification, risk factors and pathogenesis of retinal vein occlusion
  • Next Article

    A study on the stability and cutting efficiency of a domestically produced dual-blade, dual-port vitrectomy probe